Compounding pharmacies in Iowa

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

The Iowa Board of Pharmacy (Department of Inspections, Appeals, and Licensing) regulates compounding pharmacies in Iowa. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Iowa at a glance

Pharmacy regulator: Iowa Board of Pharmacy (Department of Inspections, Appeals, and Licensing)
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async allowed
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Iowa

No verified compounding pharmacies serving Iowa are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Iowa

The Iowa Board of Pharmacy, now housed in the Department of Inspections, Appeals, and Licensing, regulates pharmacies under Iowa Code chapter 155A and Board rules. Effective July 16, 2025 (after a 70-day legislative delay that was lifted in August 2025), the Board rescinded its former rules at 657 IAC, including the old compounding chapter 20, and replaced them with 481 IAC chapters 550 to 557. Compounding is now rule 481-552.22: preparations compounded under section 503A must meet USP General Chapter 795 (2023) for nonsterile and 797 (2023) for sterile compounds, and compounding a preparation that is essentially a copy of an FDA-approved drug is prohibited unless the prescriber documents a clinically significant difference for the individual patient or the approved product is listed as in shortage on the FDA drug shortages database. Iowa has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Iowa Code 155A.13A requires any pharmacy outside Iowa that delivers, dispenses, or distributes prescription drugs to an Iowa patient by any method to obtain an Iowa nonresident pharmacy license, and the applicant must submit its most recent inspection report, less than two years old, conducted while the pharmacy was operating and covering every part of its business that will be used in Iowa, along with evidence of corrective action for any deficiencies. [1] [3] [4] [5] [6]

Compounded GLP-1 access in Iowa

Iowa's telemedicine rule allows asynchronous GLP-1 programs only if the online intake is adaptive and interactive rather than a static form, and the rule also bars physicians from steering prescriptions to a specific pharmacy in exchange for any benefit (subrule 655.9(19)), which matters for bundled telehealth and pharmacy offers. [2] [9]

Research use only sellers in Iowa

Only Iowa-licensed pharmacies, including nonresident pharmacies licensed under Iowa Code 155A.13A, may dispense prescription drugs to Iowa patients. [3] [10]

Iowa notes on specific peptides

Semaglutide: Available branded by prescription, including through asynchronous telemedicine that uses an adaptive, interactive interview under rule 481-655.9. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [9]
Tirzepatide: Available branded by prescription. Compounded tirzepatide is limited to documented patient-specific needs since the 503A grace period ended February 18, 2025, and must be dispensed by an Iowa pharmacy or an Iowa-licensed nonresident pharmacy. [3] [9]

How to check a compounding pharmacy in Iowa

Search the Iowa Board of Pharmacy (Department of Inspections, Appeals, and Licensing) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Iowa requires before it ships to you. [1] [3] [4] [5] [6]
Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Iowa. [3] [10]

Common questions in Iowa

What does an out-of-state pharmacy need to ship compounded peptides to Iowa?

An Iowa nonresident pharmacy license under Iowa Code 155A.13A. It must give the Board its most recent inspection report, less than two years old and covering every part of its business used in Iowa, including any compounding. Iowa rule 481-552.22 holds compounded preparations to USP chapters 795 and 797. Check the Department of Inspections, Appeals, and Licensing lookup before ordering. [1] [3] [4]

Can an Iowa pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [7] [8]

All peptide legal questions for Iowa